A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets ...

The Edinburgh-based ceramics expert, 38, reflected on her health and 'how she's feeling about things' in a candid new article ...

A Lisbon man is battling a rare brain cancer. It’ll be a long road to recovery and the treatment is going to be costly.

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

Theo Burrell was diagnosed with incurable brain cancer at the age of just 35 - and now she's sadly shared that her tumours have grown.

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...

Antiques Roadshow star Theo Burrell has been candidly sharing updates on her cancer diagnosis ever since she was diagnosed ...

IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, ...

has demonstrated clinical activity in approximately one-third of patients with recurring glioblastoma in the completed Phase 1/2 'ROSALIE' study; EO4010 is being evaluated in metastatic colorectal ...

Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals , formed to develop transformative CNS cancer treatments with AI-powered innovation, announced today the formation of a ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated by Repotrectinib, Taletrectinib, and NVL-520 by 2034.